A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study-Reference-Cited by-同舟云学术

A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study

Published:2021-10 Issue:5 Volume:21 Page:450-457
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Takashima Tsutomu,Hara Fumikata,Iwamoto Takayuki,Uemura Yukari,Ohsumi Shozo,Yotsumoto Daisuke,Hozumi Yasuo,Watanabe Takanori,Saito Tsuyoshi,Watanabe Ken-ichi,Tsurutani Junji,Toyama Tatsuya,Akabane Hiromitsu,Nishimura Reiki,Taira Naruto,Ohashi Yasuo,Mukai Hirofumi

Funder

Taiho Pharmaceutical

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer;Watanabe;Breast Cancer,2013

2. Treatment of breast cancer;Hortobagyi;N Engl J Med,1998

3. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4);Cardoso;Ann Oncol,2018

4. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial;Koizumi;Lancet Oncol,2008

5. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial;Yamada;Lancet Oncol,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trial;eClinicalMedicine;2024-08